Jakarta: (HRNW) Indonesia gave Sinovac Biotech’s COVID-19 vaccine its first emergency use approval outside China on Monday as the world’s fourth most populous country launches nationwide inoculations to stem surging infections and deaths.
A lack of data and varying efficacy rates reported for the vaccine from different countries could undermine public trust in the rollout, according to public health experts.
Interim data from a late-stage human test of CoronaVac showed it is 65.3 per cent effective, Indonesia’s food and drugs authority BPOM said – lower than figures in Brazil and Turkey which have yet to launch mass vaccinations.
“These results meet the requirements of the World Health Organization of minimum efficacy of 50%,” BPOM head Penny K. Lukito told a news conference.
Be the first to comment on "Indonesia Approves China’s Sinovac Covid Vaccine"